Felley-Bosco E - Search Results

1

Editorial: Thy1/CD90 Surface Glycoprotein: Sensor of Microenvironment?

Felley-Bosco E, Leyton L. Felley-Bosco E, et al. Front Cell Dev Biol. 2019 Aug 13;7:162. doi: 10.3389/fcell.2019.00162. eCollection 2019. Front Cell Dev Biol. 2019. PMID: 31457010 Free PMC article. No abstract available.

2

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression.

Oehl K, Kresoja-Rakic J, Opitz I, Vrugt B, Weder W, Stahel R, Wild P, Felley-Bosco E. Oehl K, et al. Front Oncol. 2018 Feb 23;8:40. doi: 10.3389/fonc.2018.00040. eCollection 2018. Front Oncol. 2018. PMID: 29527515 Free PMC article.

3

Hedgehog Signaling in Mesothelioma: 2019 Status.

Felley-Bosco E. Felley-Bosco E. Front Genet. 2019 Nov 7;10:1121. doi: 10.3389/fgene.2019.01121. eCollection 2019. Front Genet. 2019. PMID: 31788004 Free PMC article. No abstract available.

4

Mesothelioma Driver Genes, Ferroptosis, and Therapy.

Felley-Bosco E, Gray SG. Felley-Bosco E, et al. Front Oncol. 2019 Nov 27;9:1318. doi: 10.3389/fonc.2019.01318. eCollection 2019. Front Oncol. 2019. PMID: 31828040 Free PMC article. No abstract available.

5

Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies.

Pasello G, Remon J, Felley-Bosco E. Pasello G, et al. Front Oncol. 2022 Mar 10;12:871544. doi: 10.3389/fonc.2022.871544. eCollection 2022. Front Oncol. 2022. PMID: 35359422 Free PMC article. No abstract available.

6

Erratum to: Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.

Blum W, Pecze L, Felley-Bosco E, Worthmüller-Rodriguez J, Wu L, Vrugt B, de Perrot M, Schwaller B. Blum W, et al. In Vitro Cell Dev Biol Anim. 2017 Oct;53(9):853. doi: 10.1007/s11626-017-0194-6. In Vitro Cell Dev Biol Anim. 2017. PMID: 28840527 Free PMC article. No abstract available.

7

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma.

Kresoja-Rakic J, Sulemani M, Kirschner MB, Ronner M, Reid G, Kao S, Schwaller B, Weder W, Stahel RA, Felley-Bosco E. Kresoja-Rakic J, et al. Front Genet. 2017 May 29;8:70. doi: 10.3389/fgene.2017.00070. eCollection 2017. Front Genet. 2017. PMID: 28611824 Free PMC article.

8

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.

Belyanskaya LL, Marti TM, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, Stahel RA. Belyanskaya LL, et al. Mol Cancer. 2007 Oct 22;6:66. doi: 10.1186/1476-4598-6-66. Mol Cancer. 2007. PMID: 17953743 Free PMC article.

9

Functional inactivation of NF2/merlin in human mesothelioma.

Thurneysen C, Opitz I, Kurtz S, Weder W, Stahel RA, Felley-Bosco E. Thurneysen C, et al. Lung Cancer. 2009 May;64(2):140-7. doi: 10.1016/j.lungcan.2008.08.014. Epub 2008 Oct 4. Lung Cancer. 2009. PMID: 18835652

10

Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting.

Ampollini L, Soltermann A, Felley-Bosco E, Lardinois D, Arni S, Speck RF, Weder W, Opitz I. Ampollini L, et al. Eur J Cardiothorac Surg. 2009 Mar;35(3):457-62. doi: 10.1016/j.ejcts.2008.11.030. Epub 2009 Jan 21. Eur J Cardiothorac Surg. 2009. PMID: 19162494 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page